These represent key steps toward achieving the company’s vision to commercialize compounds it has developed to prevent certain types of hearing loss. The company’s product will be the
Starting syringe work earlier, in full or partial parallel with vial development, can cut up to 18 months off time-to-market. Vetter’s self-contained, modular packages are designed to provide
This marks Hyundai’s latest move in supporting the scientific community’s efforts to improve cure rates, diminish acute toxicity from treatments and minimize the risk for late effects for
The patent application allowed by the USPTO (application number 13/063,411) relates to pharmaceutical compositions of growth hormone or parathyroid hormone and the CriticalSorb™ absorption enhancer in a form
All three countries have permission to sell commercial product from their local health authority for the treatment of patients with relapsed or refractory CD30-positive Hodgkin lymphoma (HL) and
ETI-204 is a potential target for future acquisition into the Strategic National Stockpile, the US government’s repository of critical medical supplies for biowarfare preparedness. ETI-204 is the only
This will give key stakeholders and the agency the opportunity to address any outstanding issues before the final policy is presented to the EMA’s management board for endorsement
Under the co-production partnership agreements, Pacira and Patheon will collaborate to construct dedicated Exparel manufacturing suites in Patheon’s specialty sterile manufacturing facility in Swindon. The first additional Exparel
If the same marketing-authorization application is received in parallel by EMA and TGA, the two regulators have the possibility of scientific exchange to facilitate the evaluation of the
vitaPearl is a pearl-shaped softgel that is currently the smallest complete prescription prenatal multivitamin and is the first to contain Folmax, FePlus, and pur-DHA. TherapeuticsMD chief marketing officer
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.